CClinicalTrials.gg
Sign In
CompletedNCT04516434AMPLIFYUpdated Jul 16, 2025Results posted

Amplifying Sensation in Underactive Bladder

An interventional study of Neurometer Neurotron CPT and Cystometry in Urinary Bladder, Underactive, sponsored by Duke University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-16.

Sponsored by Duke University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this study is to determine the influence of intravesical (bladder) electrical stimulation and intraurethral electrical stimulation on bothersome symptoms and bladder function in neurologically-intact adult women with underactive bladder. The investigators hypothesize that electrical stimulation will decrease bothersome urinary symptoms relative to baseline and increase voided percentage during pressure-flow studies compared to their routine clinical exam.

Read the detailed description
  1. Objective: The overall objective of this study is to improve lower urinary tract symptoms (LUTS) in adult neurologically-intact women with underactive bladder through electrical stimulation of bladder sensory nerves or urethral sensory nerves.

  2. Background and Significance: The storage and elimination of urine is regulated by neural circuits in the brain and spinal cord to coordinate function between the urinary bladder and the urethra. During micturition (bladder emptying), the elimination of urine is facilitated by bladder muscle (detrusor) contraction and urethral and pelvic floor muscle relaxation. Urine flow through the urethra also activates sensory nerves to amplify bladder contractions and maintain efficient bladder emptying. Incomplete emptying and urinary retention occur when these mechanisms are disrupted or poorly coordinated.

    Incomplete emptying due to underactive bladder is a poorly understood health concern that symptomatically affects up to 40% of the population, with the highest prevalence of symptoms in older men and women. Despite the high prevalence of symptoms, the diagnosis of an underactive bladder remains low due to the lack of consistent terminology and standardized diagnostic criteria. This results in defining underactive bladder by a symptom complex that may involve reduced motor drive (detrusor underactivity) during bladder emptying and/or reduced sensory drive during filling and emptying. Symptoms experienced by persons with underactive bladder include nocturia, urinary frequency, urgency, incontinence, slow stream, hesitancy, straining, and sensation of incomplete emptying. The most common symptoms are nocturia, slow stream, frequency, hesitancy, and the impact of these symptoms on quality of life is substantial for many patients.

    The management options for persons with underactive bladder include double-void, intermittent self-catheterization, or pharmacotherapy. However, these treatments are associated with poor quality of life and patients often fail to completely resolve the lower urinary tract symptoms (LUTS). There is a need to clarify the pathological mechanisms underlying underactive bladder to improve therapeutic outcomes. One approach to clarify reduced sensory drive is to evaluate the functional integrity of sensory nerves with quantitative sensory testing. Current perception threshold (CPT) testing delivers electrical stimulation to activate nerve fibers that evoke sensory perception, and changes in bladder sensory pathways were demonstrated in persons with diabetic detrusor underactivity. These diagnostic tests, however, have not been applied to neurologically intact adult women with underactive bladder and may provide insight into pathological sensory dysfunction.

    The proposed research will quantify sensory nerve sensitivity in the bladder and urethra in adult women with underactive bladder. The investigators will then amplify sensory nerve activity via continuous electrical stimulation to improve LUTS associated with underactive bladder. Achieving the proposed objectives will establish a prognostic marker for rationally guided electrical stimulation in women with underactive bladder. Understanding how these mechanisms contribute to impaired emptying in underactive bladder will enable the development of novel therapeutics to enhance quality of life.

  3. Subject Recruitment: Established patients with underactive bladder will be identified by MaestroCare chart review. New patients with underactive bladder will be identified by Duke urogynecologists who see patients at one of two urogynecologic offices (Navaho Clinic in Raleigh or Patterson Place in Durham).
  4. Design and Procedures: The investigators will perform a parallel interventional study with two non-randomized study arms (bladder stimulation and urethral stimulation). Potential participants will be screened remotely by email via RedCap by completing a questionnaire to determine bothersome symptoms and perceptions of bladder function. Potential participants that meet eligibility criteria will be scheduled for an in person study procedure visit, where informed consent will be signed. Participants will then undergo current perception threshold (CPT) testing, where electrical stimulation will be delivered via a catheter to the urethra (intraurethral) and bladder (intravesical) to evoke sensation. The CPT results will inform whether the participant receives an investigational session of intravesical (bladder) electrical stimulation or intraurethral electrical stimulation. Following electrical stimulation, the participant will undergo urodynamic studies (cystometrogram, pressure-flow study) to assess bladder function after the investigational stimulation procedures. The participant will also be asked to complete remotely by email a post-study symptom RedCap questionnaire 7 days after study completion.
02

Conditions studied

  • Urinary Bladder, Underactive

Keywords

  • electrical stimulation
  • urodynamics
  • bladder
  • urethra
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Females ages 18 and older
  • Able to provide informed consent and agree to the study risks
  • Willing to withdraw from medications affecting urination for the 48 hours prior to the procedure (e.g., alpha-adrenergic antagonists, cholinergic agonists, cholinesterase inhibitors)

  • Has the below response to 2 of the 3 questions:

    1. Questions regarding self-reported poor sensation during bladder filling or emptying (one or more of the below)

      • In the past 7 days, where did the participant feel sensations when needing to urinate? Answer: "No" response for Bladder Area
      • In the past 7 days, how often did the participant have no sensation of urine flow while urinating? Answer: "Most of the time" or "Every time" response
      • In the past 7 days, how often did the participant feel that the bladder was not completely empty after urination? Answer: "Most of the time" or "Every time" response

    2. Questions regarding self-reported bothersome urinary symptoms (one or more of the below)

      • In the past 7 days, how satisfied was the participant with bladder function? Answer: "Not at all satisfied" or "Somewhat satisfied" response
      • In the past 7 days, how bothered was the participant by urinary symptoms? Answer: "Very bothered" or "Extremely bothered" response
    3. Standard uroflowmetry with a voiding efficiency (voided volume / voided volume + residual volume) of \< 80%, voided volume + residual volume must be >150ml for measurement

Exclusion criteria

Exclusion Criteria:

  • Preexisting neurological impairment (e.g., spinal cord injury, multiple sclerosis, Guillain-Barre, cauda equina syndrome, cerebrovascular accident, Parkinson's disease, traumatic brain injury)
  • Functional obstruction demonstrated by either elevated pelvic floor activity on EMG during standard pressure flow study or high tone pelvic floor on clinical exam)
  • Pelvic organ prolapse beyond introitus
  • Active urinary tract infection (candidate would be deferred until treated)
  • Positive pregnancy test
  • Less than 6 weeks postpartum
  • Unevaluated hematuria
  • Urethral stricture/stenosis
  • Surgical obstruction i.e., urinary retention due to obstructive sling or other anti incontinence procedure
  • Surgical procedures to increase bladder capacity (e.g., augmentation cystoplasty)
  • Active sacral neuromodulation or ongoing posterior tibial nerve stimulation sessions
  • Botulinum toxin injection in the past six months
  • History of genitourinary or gastrointestinal cancer
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Intraurethral Electrical Stimulation

    This procedure is specific to the urethral stimulation arm. A sterile stimulation catheter (custom, 7-French) will be placed in the urethra and positioned with the electrode contact 10-14 mm from the bladder neck to stimulate the proximal urethra. A single return electrode will also be placed on the abdominal skin above the pubic bone. Stimuli will be delivered as 0.2 ms charge-balanced biphasic rectangular current pulses. Stimulation frequency will be 2-20 Hz and amplitude will be adjusted individually to 80% of the maximum tolerable intensity. Electrical stimulation will be applied to the proximal urethra at "strong desire to void" during cystometry. The participant will then be given permission to void at "maximum cystometric capacity" with continuous intraurethral stimulation.

    Device: Neurometer Neurotron CPT · Procedure: Cystometry · Procedure: Pressure-flow study

  • Experimental
    Intravesical Electrical Stimulation

    This procedure is specific to the bladder stimulation arm. A sterile stimulation catheter (custom, 7-French) will be placed in the bladder through the urethra and the electrode contacts will be positioned to be floating within the bladder. A single return electrode will also be placed on the abdominal skin above the pubic bone. Stimuli will be delivered as 0.2 ms charge-balanced biphasic rectangular current pulses. Stimulation frequency will be set at 20 Hz and amplitude will be adjusted individually to 80% of the maximum tolerable intensity. Electrical stimulation will be applied to bladder sensory nerves for up to 60 minutes prior to the start of urodynamic studies.

    Device: Neurometer Neurotron CPT · Procedure: Cystometry · Procedure: Pressure-flow study

Interventions

  • DeviceNeurometer Neurotron CPT

    All participants will undergo CPT testing. A Neurotron catheter (12-French) with electrode will be inserted through the urethra into the bladder. The catheter balloon will be inflated and positioned at the urethrovesical junction to stimulate the urethra 10-14 mm from the bladder neck. For bladder stimulation, the catheter balloon will be deflated and the catheter will be advanced into the bladder. The device will deliver sine wave stimulus pulses at 5, 250, and 2,000 Hz. CPT will be established using an automated forced choice paradigm by the method of levels. Testing order of the bladder and urethra will be randomized between participants.

  • ProcedureCystometry

    After bladder stimulation or during intraurethral stimulation, cystometry will be performed to assess bladder sensation and storage. A dual-chamber 8-French catheter will be passed through the urethra into the bladder for retrograde filling. A second 8-French catheter will be placed in the vagina to measure intra-abdominal pressure. A stimulation electrode catheter will only be inserted in the intraurethral stimulation arm. EMG pads will then be placed at 3 and 9 o'clock on each side of the perineum. The bladder will then be filled with room-temperature sterile saline solution in a retrograde fashion using a pump. Bladder sensation and urgency will be assessed while filling.

  • ProcedurePressure-flow study

    A pressure flow study will be performed to evaluate voiding function after stimulation. The transurethral and intra-vaginal catheters are left in place after cystometry and the participant will be asked to void around them, into a commode. Bladder and abdominal pressures will be recorded, as well as urine flow over time.

05

What researchers measure

Primary outcomes

  1. Voiding Efficiency

    Use of intraurethral electrical stimulation or intravesical electrical stimulation to assess increase in voided percentage during pressure-flow studies. Voiding efficiency is calculated as voided volume divided by the sum of voided volume and residual volume.

    Time frame: Baseline, pressure-flow study (up to 60 minutes)

  2. Change in Bothersome Symptoms and Sensation

    Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) to assess whether electrical stimulation decreases urinary bothersome symptoms and increases bladder sensation during filling and emptying. Scores range from 0 (least severe) to 100 (most severe). Higher scores indicate greater severity of lower urinary tract symptoms.

    Time frame: baseline and post study procedures, up to 60 minutes

Secondary outcomes

  1. Current Perception Threshold

    Assess bladder or urethral current perception threshold (CPT) in women with underactive bladder compared to normative values. The CPT value determined by the device is defined as the average of the minimum amplitude of the stimulus consistently detected and the stimulus 40 µA lower that was consistently not detected.

    Time frame: CPT, up to 60 minutes

  2. Cystometry Volume

    Use of intravesical electrical stimulation to assess volumes during cystometry. Bladder sensation and urgency assessed at volume of first sensation during bladder filling, first desire to void, strong desire to void, and maximum cystometric capacity.

    Time frame: cystometry before stimulation and after stimulation (up to 60 minutes)

  3. Bladder Contraction Strength

    Use of intraurethral electrical stimulation to assess contraction strength relative to baseline. Bladder pressure (cmH2O) is recorded over time during voiding.

    Time frame: Baseline, pressure-flow study (up to 60 minutes)

  4. Bladder Contraction Duration

    Use of intraurethral electrical stimulation to assess flow duration during a bladder contraction relative to baseline.

    Time frame: Baseline, pressure-flow study (up to 60 minutes)

06

Results

Posted Jul 16, 2025

Participant flow

Participant flow — Overall Study
MilestoneIntravesical Electrical StimulationIntraurethral Electrical Stimulation
Started128
Completed128
Not completed00

Outcome measures

PrimaryVoiding Efficiency

Use of intraurethral electrical stimulation or intravesical electrical stimulation to assess increase in voided percentage during pressure-flow studies. Voiding efficiency is calculated as voided volume divided by the sum of voided volume and residual volume.

Time frame:
Baseline, pressure-flow study (up to 60 minutes)
Reported as:
Mean · voided percentage
Voiding Efficiency
voided percentageIntravesical Electrical StimulationIntraurethral Electrical Stimulation
Baseline32 ± 3153 ± 22
Pressure-flow study (up to 60 minutes)43 ± 3746 ± 27
Statistical analysis
  • Intravesical Electrical Stimulation · Mixed Models Analysis · p = 1
  • Intraurethral Electrical Stimulation · Mixed Models Analysis · p = 0.99
PrimaryChange in Bothersome Symptoms and Sensation

Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) to assess whether electrical stimulation decreases urinary bothersome symptoms and increases bladder sensation during filling and emptying. Scores range from 0 (least severe) to 100 (most severe). Higher scores indicate greater severity of lower urinary tract symptoms.

Time frame:
baseline and post study procedures, up to 60 minutes
Reported as:
Mean · CASUS questionnaire scores
Change in Bothersome Symptoms and Sensation
CASUS questionnaire scoresIntravesical Electrical StimulationIntraurethral Electrical Stimulation
Baseline52 ± 1553 ± 11
Post Study Procedures46 ± 1639 ± 18
Statistical analysis
  • Intravesical Electrical Stimulation · Mixed Models Analysis · p = 0.08
  • Intraurethral Electrical Stimulation · Mixed Models Analysis · p = 0.045
SecondaryCurrent Perception Threshold

Assess bladder or urethral current perception threshold (CPT) in women with underactive bladder compared to normative values. The CPT value determined by the device is defined as the average of the minimum amplitude of the stimulus consistently detected and the stimulus 40 µA lower that was consistently not detected.

Time frame:
CPT, up to 60 minutes
Reported as:
Mean · mA (maximum amplitude)
Current Perception Threshold
mA (maximum amplitude)Intravesical Electrical StimulationIntraurethral Electrical Stimulation
5 Hz8.57 ± 3.238.27 ± 3.61
250 Hz9.99 ± 0.009.04 ± 0.40
2000 Hz9.99 ± 0.009.99 ± 0.00
SecondaryCystometry Volume

Use of intravesical electrical stimulation to assess volumes during cystometry. Bladder sensation and urgency assessed at volume of first sensation during bladder filling, first desire to void, strong desire to void, and maximum cystometric capacity.

Time frame:
cystometry before stimulation and after stimulation (up to 60 minutes)
Reported as:
Mean · mL
Cystometry Volume
mLIntravesical Electrical StimulationIntraurethral Electrical Stimulation
first sensation of bladder filling - before stimulation290 ± 159253 ± 122
first sensation of bladder filling - after stimulation281 ± 146357 ± 135
maximum cystometric capacity - before stimulation517 ± 263458 ± 225
maximum cystometric capacity - after stimulation528 ± 253646 ± 211
Statistical analysis
  • Intravesical Electrical Stimulation · Mixed Models Analysis · p = 1
  • Intraurethral Electrical Stimulation · Mixed Models Analysis · p = 0.41
  • Intravesical Electrical Stimulation · Mixed Models Analysis · p = 1
  • Intraurethral Electrical Stimulation · Mixed Models Analysis · p = 0.01
SecondaryBladder Contraction Strength

Use of intraurethral electrical stimulation to assess contraction strength relative to baseline. Bladder pressure (cmH2O) is recorded over time during voiding.

Time frame:
Baseline, pressure-flow study (up to 60 minutes)
Reported as:
Mean · cmH2O
Bladder Contraction Strength
cmH2OIntravesical Electrical StimulationIntraurethral Electrical Stimulation
Baseline11 ± 3233 ± 41
Pressure-flow study (up to 60 minutes)21 ± 1825 ± 27
Statistical analysis
  • Intravesical Electrical Stimulation · Mixed Models Analysis · p = 1
  • Intraurethral Electrical Stimulation · Mixed Models Analysis · p = 1
SecondaryBladder Contraction Duration

Use of intraurethral electrical stimulation to assess flow duration during a bladder contraction relative to baseline.

Time frame:
Baseline, pressure-flow study (up to 60 minutes)
Reported as:
Mean · mL/s
Bladder Contraction Duration
mL/sIntravesical Electrical StimulationIntraurethral Electrical Stimulation
Baseline8 ± 315 ± 3
Pressure-flow study (up to 60 minutes)15 ± 1213 ± 7
Statistical analysis
  • Intravesical Electrical Stimulation · Mixed Models Analysis · p = 1
  • Intraurethral Electrical Stimulation · Mixed Models Analysis · p = 0.99

Adverse events

Collected over One month post study completion. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intravesical Electrical Stimulation0/12 (0%)0/12 (0%)3/12 (25%)
Intraurethral Electrical Stimulation0/8 (0%)0/8 (0%)0/8 (0%)
Most frequent other events
Most frequent other events
EventIntravesical Electrical StimulationIntraurethral Electrical Stimulation
Urinary tract infectionRenal and urinary disorders3/120/8

Baseline characteristics

Age, Continuous
Age, Continuous(years)Intravesical Electrical StimulationIntraurethral Electrical StimulationTotal
Mean69 ± 667 ± 468 ± 12
Sex: Female, Male
Sex: Female, Male(Participants)Intravesical Electrical StimulationIntraurethral Electrical StimulationTotal
Female12820
Male000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Intravesical Electrical StimulationIntraurethral Electrical StimulationTotal
Hispanic or Latino000
Not Hispanic or Latino11819
Unknown or Not Reported101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Intravesical Electrical StimulationIntraurethral Electrical StimulationTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American112
White10717
More than one race000
Unknown or Not Reported101
Region of Enrollment
Region of Enrollment(participants)Intravesical Electrical StimulationIntraurethral Electrical StimulationTotal
United States12820
07

Study locations

1 site
  • Duke Medical Plaza Patterson Place
    Durham, North Carolina 27707, United States
08

References and documents

Publications

  • Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008 Jun;9(6):453-66. doi: 10.1038/nrn2401. PubMed 18490916 ↗
  • Jung SY, Fraser MO, Ozawa H, Yokoyama O, Yoshiyama M, De Groat WC, Chancellor MB. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol. 1999 Jul;162(1):204-12. doi: 10.1097/00005392-199907000-00069. PubMed 10379788 ↗
  • Bump RC. The urethrodetrusor facilitative reflex in women: results of urethral perfusion studies. Am J Obstet Gynecol. 2000 Apr;182(4):794-802; discussion 802-4. doi: 10.1016/s0002-9378(00)70328-0. PubMed 10764455 ↗
  • Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014 Feb;65(2):389-98. doi: 10.1016/j.eururo.2013.10.015. Epub 2013 Oct 26. PubMed 24184024 ↗
  • Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, Oh JJ, Lee SC, Jeong CW, Yoon CY, Hong SK, Byun SS, Lee SE. Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women. Korean J Urol. 2012 May;53(5):342-8. doi: 10.4111/kju.2012.53.5.342. Epub 2012 May 18. PubMed 22670194 ↗
  • Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, Drake MJ, Yamaguchi O, Abrams P, Smith PP. The underactive bladder: a new clinical concept? Eur Urol. 2015 Sep;68(3):351-3. doi: 10.1016/j.eururo.2015.02.030. Epub 2015 Mar 11. PubMed 25770481 ↗
  • Gammie A, Kaper M, Dorrepaal C, Kos T, Abrams P. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol. 2016 Feb;69(2):361-9. doi: 10.1016/j.eururo.2015.08.014. Epub 2015 Aug 28. PubMed 26318706 ↗
  • Uren AD, Cotterill N, Harding C, Hillary C, Chapple C, Klaver M, Bongaerts D, Hakimi Z, Abrams P. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol. 2017 Sep;72(3):402-407. doi: 10.1016/j.eururo.2017.03.045. Epub 2017 Apr 8. PubMed 28400168 ↗
  • Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive bladder. Rev Urol. 2013;15(1):11-22. PubMed 23671401 ↗
  • Ukimura O, Ushijima S, Honjo H, Iwata T, Suzuki K, Hirahara N, Okihara K, Mizutani Y, Kawauchi A, Miki T. Neuroselective current perception threshold evaluation of bladder mucosal sensory function. Eur Urol. 2004 Jan;45(1):70-6. doi: 10.1016/j.eururo.2003.08.004. PubMed 14667519 ↗
  • Kenton K, Simmons J, FitzGerald MP, Lowenstein L, Brubaker L. Urethral and bladder current perception thresholds: normative data in women. J Urol. 2007 Jul;178(1):189-92; discussion 192. doi: 10.1016/j.juro.2007.03.032. Epub 2007 May 17. PubMed 17499783 ↗
  • Lee WC, Wu HP, Tai TY, Yu HJ, Chiang PH. Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J Urol. 2009 Jan;181(1):198-203. doi: 10.1016/j.juro.2008.09.021. Epub 2008 Nov 14. PubMed 19013605 ↗
  • Cella D, Smith AR, Griffith JW, Flynn KE, Bradley CS, Gillespie BW, Kirkali Z, Talaty P, Jelovsek JE, Helfand BT, Weinfurt KP; LURN Study Group. A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire. Neurourol Urodyn. 2019 Aug;38(6):1751-1759. doi: 10.1002/nau.24067. Epub 2019 Jun 21. PubMed 31225927 ↗
  • Gladh G, Mattsson S, Lindstrom S. Intravesical electrical stimulation in the treatment of micturition dysfunction in children. Neurourol Urodyn. 2003;22(3):233-42. doi: 10.1002/nau.10078. PubMed 12707874 ↗
  • Jiang CH, Lindstrom S. Optimal conditions for the long-term modulation of the micturition reflex by intravesical electrical stimulation: an experimental study in the rat. BJU Int. 1999 Mar;83(4):483-7. doi: 10.1046/j.1464-410x.1999.00947.x. PubMed 10210575 ↗
  • Deng H, Liao L, Wu J, Chen G, Li X, Wang Z, Wan L. Clinical efficacy of intravesical electrical stimulation on detrusor underactivity: 8 Years of experience from a single center. Medicine (Baltimore). 2017 Sep;96(38):e8020. doi: 10.1097/MD.0000000000008020. PubMed 28930838 ↗
  • Gustafson KJ, Creasey GH, Grill WM. A urethral afferent mediated excitatory bladder reflex exists in humans. Neurosci Lett. 2004 Apr 22;360(1-2):9-12. doi: 10.1016/j.neulet.2004.01.001. PubMed 15082166 ↗
  • Yoo PB, Horvath EE, Amundsen CL, Webster GD, Grill WM. Multiple pudendal sensory pathways reflexly modulate bladder and urethral activity in patients with spinal cord injury. J Urol. 2011 Feb;185(2):737-43. doi: 10.1016/j.juro.2010.09.079. Epub 2010 Dec 18. PubMed 21168860 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 10, 2024
  • Informed consent form · Apr 10, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT04516434
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Aug 18, 2020
Start date
Sep 1, 2021
Primary completion
Sep 4, 2024
Completion
Sep 27, 2024
Results posted
Jul 16, 2025
Last update
Jul 16, 2025

Study contacts

Cindy L Amundsen, MD
study chair · Duke University
Em Abbott, PhD
principal investigator · Duke University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Urinary Bladder, Underactive→

Other studies from this sponsor

Duke University

Start the discussion